Company / Gross Profit
GT Biopharma, Inc. Gross Profit History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
-
FY2017
5-year range
$0 / $142.0K
FY2013-FY2017
Trend
-100.0%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $4,000 to $0 over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2017, gross profit decreased 100.0% year-over-year.
- Peak gross profit was recorded in FY2013.
- Lowest gross profit in the period was in FY2011.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | - | - |
| FY2017 | $0 | -100.0% |
| FY2016 | $27.0K | +575.0% |
| FY2015 | $4.0K | -97.2% |
| FY2014 | $142.0K | -42.7% |
| FY2013 | $248.0K | +1227.3% |
| FY2012 | -$22.0K | +59.3% |
| FY2011 | -$54.0K | - |
As of FY2017 · SEC 10-K · Updated Jun 24, 2026